Pressure BioSciences (OTCQB: PBIO) (“PBI”) reported financial results for the third quarter of 2017 today, along with a business update and limited guidance regarding its expected revenue for the rest of FY 2017. Among other highlights, the company reported a record-breaking total revenue of $646,061, an increase of 21% from $535,334 in the third quarter…
Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning announced it has appointed Craig J. Brown, P. Eng., to the company’s Scientific Advisory Council, effective immediately. Brown is a highly respected hydrometallurgical expert with over 45 years of experience in the field. Additionally, the company has initiated the first phase of test work on…
Online-to-offline (O2O) integrated platform operator Moxian, Inc. (NASDAQ: MOXC) is successfully targeting key markets in China with its paid platforms, resulting in various revenue streams. An article discussing this reads: “Key to MOXC’s unique attractiveness is its built-in UnionPay digital money collection process app — a highly desired feature by merchants (http://dtn.fm/E9qBe). That processing also…
Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI”), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, announced this morning that the company will host a conference call, during which the company will provide a business update and discuss financial results for the third quarter of 2017. The call will…
Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), an energy exploration and development company, remains focused on its Bristol Dry Lake lithium brine project positioned in the Mojave Desert in California. An article discussing this reads: “Key to the project’s success is the area’s excellent mining infrastructure that tackles the primary challenges facing lithium…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has regained NYSE American listing compliance. The company received a letter on November 9, 2017, from NYSE Regulation stating that it is currently in compliance with the NYSE American LLC continued…
Pressure BioSciences, Inc. (OTCQB: PBIO) is engaged in the development and sale of innovative solutions for the worldwide life sciences industry. The company is advancing in the industry, with its patented high pressure cycling technology. PBIO also recently received patents for its Ultra Shear Technology. An article discussing this reads: “Pressure BioSciences, which completed 2016…
Moxian, Inc. (NASDAQ: MOXC) is an online-to-offline (O2O) integrated platform operator in China. The company offers two apps, Moxian+ User and Moxian+ Business, that enable businesses to reward consumer loyalty in an O2O pipeline. An article discussing this reads: “Retail analyst iResearch estimates this year’s O2O e-commerce sales in China alone will amount to $78.4…
India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions. The company is employing a distinctive strategy to bring these drug candidates to market. An article discussing this reads: “IGC’s unique strategy reduces regulatory approval time and development costs because its chosen…
In September, Moxian, Inc. (NASDAQ: MOXC) announced that Hao Qing Hu was named the company’s new chief executive officer. As the leadership changed, so did the company’s strategy. The company is now focused on larger retailers in China and how to help these clients secure more customers. An article discussing this reads: “Less than a…
As a first mover in the cannabis-based combination therapy space, India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex. The classification as a combination therapy enables the company to bring the product to market significantly faster than most pharmaceuticals,…
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, this morning announced that Professor Tiannan Guo’s laboratory at Westlake Institute for Advanced Study (“WIAS”) has been named the company’s first Center of Excellence (“CoE”) in China.…
Canadian energy exploration and development company Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning announced its entry into a memorandum of understanding with TETRA Technologies, Inc. (NYSE: TTI) aimed at securing access to additional operating and permitted land consisting of approximately 12,100 acres in Bristol Dry Lake and up to 11,840 acres…
Moxian, Inc. (NASDAQ: MOXC) has recently shifted its focus in China in an effort to increase its share of the online-to-offline (O2O) market, grow processing fees, and enhance commission revenues on sales processed by its UnionPay mobile module. An article discussing this reads: “The new strategy is part of MOXC’s shift toward gaining more market…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has entered into a memorandum of understanding with MediCann Handels GmbH for the import and distribution of IGC’s cannabinoid-based therapies to pharmacies in Germany. Under the terms of the MOU, MediCann…
It is estimated that China will experience almost $2 trillion in new consumer-driven consumption by 2021, and Chinese consumers are about twice as likely to use a mobile device to make retail purchases as consumers in Europe and the United States. Right in line to capitalize on this, Moxian, Inc. (NASDAQ: MOXC) has recently upgraded…
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced supercritical fluid (“SCF”)-based toll processors. The goal of the collaboration is to combine PBI’s recently patented Ultra Shear Technology with…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, the expression of GSK3β is reduced by as much as 62…
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://dtn.fm/tQo00). IGC is engineering genetic cell lines which demonstrate that, at various concentrations of tetrahydrocannabinol (THC), the protein Aβ decreases as much as…
Licensed Canadian cannabis cultivation company Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) recently entered into a collaboration and licensing agreement with Canntab Therapeutics Limited to collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of Canntab’s patent-pending oral sustained release cannabinoid formulation. The agreement grants Emblem the exclusive right to Canntab’s patents and…